Left ventricular assist device implantation in patients with a history of malignancy.
Yeahwa HongLaura M SeeseGavin W HickeyShangzhen ChenMichael A MathierArman KilicPublished in: Journal of cardiac surgery (2020)
Although a history of malignancy is associated with reduced survival after LVAD implantation, more than half of the patients are alive at 2 years. This combined with the fact that most do not die from causes directly related to their cancer suggest that LVAD implantation is reasonable to perform in carefully selected patients with a history of malignancy.